Matthew Royle examines developments in the efforts to widen access to medicines in the poorest countries.
A legal toolkit for life sciences companies and their investors providing access to information on:
Paul England and Verena Bertram provide a step-by-step guide to Unified Patent Court opt-out... read more
Paul England looks at how the courts have addressed pharmaceutical second medical use patents cases in a number of important European jurisdictions over the past year... read more
Matthew Royle discusses the CJEU ruling in Teva v the European Medicines Agency concerning the market exclusivity period attaching to orphan medicinal products... read more
Receive our monthly newsletter keeping you updated on recent developments and events in the Life Sciences sector...